3 Einträge gefunden

1. Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial

   1. Klein, Eva-Maria
   2. Tichy, Diana
   3. Salwender, Hans J
   4. Mai, Elias K
   5. Duerig, Jan
   6. Weisel, Katja C
   7. Benner, Axel

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma

   1. Salwender, Hans
   2. Bertsch, Uta
   3. Weisel, Katja
   4. Duerig, Jan
   5. Kunz, Christina
   6. Benner, Axel
   7. Blau, Igor W

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
3. Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial

   1. Weisel, Katja C
   2. Scheid, Christof
   3. Zago, Manola
   4. Besemer, Britta
   5. Mai, Elias K
   6. Haenel, Mathias
   7. Duerig, Jan

   2019 - Forschungsinformationssystem des UKE